Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox Co    CLX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 03:26pm CET

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX CO
01/23 CLOROX CO : ex-dividend day
01/03 CLOROX : Announces Feb. 3 Webcast of Second-Quarter Fiscal Year 2017 Results
2016 CLOROX : Patent Issued for Refill Article for Wipes Dispenser and Assembly of Bo..
2016 CLOROX : New Study Reveals Women May Suffer From Digestive Health Issues In Sile..
2016 CLOROX : Recognized as 'Best Place to Work' by Human Rights Campaign, Glassdoor
2016 CLOROX : Take a 360 View into How Safe Water Can Change a Community
2016 CLOROX : Patent Issued for Targeted Performance of Hypohalite Methods (USPTO 949..
2016 CLOROX : Pine-Sol® Launches "Makers of Home"
2016 CLOROX CO /DE/ : Change in Directors or Principal Officers, Submission of Matter..
2016 CLOROX : Patent Issued for Refill Article for Wipes Dispenser and Assembly of Bo..
More news
Sector news : Household Products - NEC
01/06 RECKITT BENCKISER : South Korea court convicts ex-Reckitt Benckiser unit chief i..
2016 FTSE nudges higher though banks, Ashtead slide
2016DJRECKITT BENCKISER : CFO Buys 8,959 Shares/7,219P
2016DJShine Comes Off Consumer-Goods Firms -- WSJ
2016DJShine Comes Off Big Consumer-Product Companies
More sector news : Household Products - NEC
News from SeekingAlpha
01/19 Stocks Going Ex-Dividend The Fourth Week Of January
01/09 Dripping For Fun And Profit
01/09 Free Market Capitalist December Dividend Income
01/09 Barclays lifts Clorox to Equal-Weight
01/05 The 'Best' And 'Worst' Dividend Aristocrats Of 2016
Advertisement
Financials ($)
Sales 2017 5 966 M
EBIT 2017 1 117 M
Net income 2017 701 M
Debt 2017 1 870 M
Yield 2017 2,66%
P/E ratio 2017 22,84
P/E ratio 2018 21,39
EV / Sales 2017 2,93x
EV / Sales 2018 2,83x
Capitalization 15 632 M
More Financials
Chart CLOROX CO
Duration : Period :
Clorox Co Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Full-screen chart
Technical analysis trends CLOROX CO
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 122 $
Spread / Average Target 0,10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby COO-Cleaning, International & Corporate Strategy
Stephen M. Robb Chief Financial Officer & Executive Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX CO0.82%15 632
RECKITT BENCKISER GROU..-0.89%59 095
UNILEVER INDONESIA TBK..--.--%23 176
CHURCH & DWIGHT CO., I..3.03%11 779
LION CORP-1.62%4 985
KOBAYASHI PHARMACEUTIC..-1.20%3 709
More Results